An AI-Driven Genomics Company Is Turning to Drugs

Deep Genomics aims to develop drugs by using deep learning to find patterns in genomic and medical data.

from Computing – MIT Technology Review https://www.technologyreview.com/s/604305/an-ai-driven-genomics-company-is-turning-to-drugs/

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s